Introduction
Porto-sinusoidal vascular disease (PSVD) is an uncommon liver disease involving the intrahepatic microvasculature, whose development is promoted by various pro-thrombotic factors. Among these is pernicious anemia (PA), an autoimmune gastritis leading to vitamin B12 malabsorption, whose deficiency induces hyperhomocysteinemia, a well-established thrombogenic factor.
Aims & Methods
Through this work, we report the prevalence of PA within a cohort of patients with PSVD, along with their clinical, biological, and evolutive features.
This was a retrospective single-center study including all patients diagnosed with PSVD between 2016 and 2026, among whom those with associated PA were identified.
Results
Over the study period, 68 patients were diagnosed with PSVD. PA was identified in 7 patients, yielding a prevalence of 10.3%. The mean age was 40.7 years, with a female predominance (male-to-female ratio 3:4).
Clinically, an anemic syndrome was present in all patients at diagnosis; abdominal pain was reported in 5 cases (71%), and upper gastrointestinal bleeding in 1 patient (14%). Physical examination revealed collateral venous circulation in 4 patients (57%), splenomegaly in 6 (86%), and hepatomegaly in 2 (28%).
Abdominal ultrasound showed signs of portal hypertension in all patients, including splenomegaly and collateral circulation observed in 6 cases each (86%) and portal vein dilatation in 5 (71%).
Liver biopsy demonstrated the absence of cirrhosis in all patients and showed histological features consistent with PSVD, allowing diagnostic confirmation.
Upper gastrointestinal endoscopy disclosed esophageal varices in 5 cases (83%), mostly grade II; one patient had no varices, and vascular ectasia was noted in one case. Fundic atrophy suggestive of autoimmune gastritis was observed in 5 patients (83%).
Biological assessment showed hyperhomocysteinemia associated with vitamin B12 deficiency, and the diagnosis of PA was confirmed by immunological and histological findings: anti-intrinsic factor antibodies were positive in 5 patients (including 3 with concomitant anti-parietal cell antibodies), while isolated anti-parietal cell antibodies were observed in 1 case. Gastric histology showed fundic atrophy in 4 cases, intestinal metaplasia in 3, and enterochromaffin-like cell hyperplasia in 1 patient.
All patients received vitamin B12 injections, and portal hypertension was managed through endoscopic and pharmacological treatments.
Follow-up showed the normalization of vitamin B12 and homocysteine levels, along with stabilization of portal hypertension.
Conclusion
Pernicious anemia may represent an under-recognized and potentially reversible prothrombotic factor in PSVD. Systematic screening for vitamin B12 deficiency and hyperhomocysteinemia should be considered to improve etiological diagnosis and guide management.